0 views

Uploaded by Dorai Yogaraja

Point C Calculations

save

- Lung Cancer (2)
- Concurrent Radiotherapy and Weekly Paclitaxel for Locally Advanced Squmous Cell Carcinoma of Uterine Cervix–Treated Patients at Rural Centre in India
- south african radiographer journal
- Radiation Hazard
- 10.1007@s00405-018-4985-5
- Radiology Final Study Guide
- wbi vs apbi ruth
- Accurate Respiration Measurement Using DC-Coupled Continuous-Wave Radar Sensor for Motion-Adaptive Cancer Radiotherapy
- Radiotherapy for Your Lung at Velindre Hospital
- radiationsafetyresearch-uwlax
- Oral Cancer
- Malignant Spinal Cord Compression-- Dealing the most common --Mets
- Acute Effects of Radiation Injury
- para-aortic or nodal irradiation evaluation
- fun with radiation-e2
- Colon Cancer
- Impact of PET CT motion correction in minimizing the gross tumor volume in nonsmall cell lung cancer
- case study final
- Breast Cancer Clinical
- Evaluacion Clinica e Histopatologica Del Sucralfate Para Tto de Mucositis
- safety essay
- terapi(bhs inggris)
- Leukemia Treatment in India | Low Cost Leukemia Treatment in India
- Introduction Waste
- 259_2013_Article_2510
- brain assignment
- Ppt for Lung Cancer
- Nasopharyngeal Cancer Complete
- Oncology Nursing Handouts 1
- Paediatric Soft Tissue Tumours
- Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future
- Dispatches from Pluto: Lost and Found in the Mississippi Delta
- The Innovators: How a Group of Hackers, Geniuses, and Geeks Created the Digital Revolution
- Sapiens: A Brief History of Humankind
- Yes Please
- The Unwinding: An Inner History of the New America
- Grand Pursuit: The Story of Economic Genius
- This Changes Everything: Capitalism vs. The Climate
- A Heartbreaking Work Of Staggering Genius: A Memoir Based on a True Story
- The Emperor of All Maladies: A Biography of Cancer
- The Prize: The Epic Quest for Oil, Money & Power
- John Adams
- Devil in the Grove: Thurgood Marshall, the Groveland Boys, and the Dawn of a New America
- The World Is Flat 3.0: A Brief History of the Twenty-first Century
- Rise of ISIS: A Threat We Can't Ignore
- The Hard Thing About Hard Things: Building a Business When There Are No Easy Answers
- Smart People Should Build Things: How to Restore Our Culture of Achievement, Build a Path for Entrepreneurs, and Create New Jobs in America
- Team of Rivals: The Political Genius of Abraham Lincoln
- The New Confessions of an Economic Hit Man
- How To Win Friends and Influence People
- Angela's Ashes: A Memoir
- Steve Jobs
- Bad Feminist: Essays
- You Too Can Have a Body Like Mine: A Novel
- The Incarnations: A Novel
- The Light Between Oceans: A Novel
- Leaving Berlin: A Novel
- The Silver Linings Playbook: A Novel
- The Sympathizer: A Novel (Pulitzer Prize for Fiction)
- Extremely Loud and Incredibly Close: A Novel
- A Man Called Ove: A Novel
- The Master
- Bel Canto
- We Are Not Ourselves: A Novel
- The First Bad Man: A Novel
- The Rosie Project: A Novel
- The Blazing World: A Novel
- Brooklyn: A Novel
- The Flamethrowers: A Novel
- Life of Pi
- The Love Affairs of Nathaniel P.: A Novel
- The Bonfire of the Vanities: A Novel
- Lovers at the Chameleon Club, Paris 1932: A Novel
- The Perks of Being a Wallflower
- A Prayer for Owen Meany: A Novel
- The Cider House Rules
- Wolf Hall: A Novel
- The Art of Racing in the Rain: A Novel
- The Wallcreeper
- Interpreter of Maladies
- The Kitchen House: A Novel
- Beautiful Ruins: A Novel
- Good in Bed

You are on page 1of 7

:

**Description Control Console secondary barrier along North
**

wall

Occupancy Factor 1

Use Factor 1 for scatter barriers

Workload 15MV (IMRT) 1170 Gy/wk

Workload 10MV (IMRT) 765 Gy/wk

Workload 06MV (IMRT) 945 Gy/wk

Distance from target to patient, dsca 1m

Distance from isocenter to point ‘C’ 7.6m

Dose per week outside barrier (P) −3

0.1 ×10 Sv

As seen for point ‘D’, patient scatter will be negligible at this point. We will only consider leakage dose:

Leakage Calculation

P ×d L2 0.1 ×10−3 ×(7.62 ) 0.005776

B L ( 06 MV )= = = =0.00611

10−3 × W ×T 0. 001 ×945 ×1 0.945

Then the number of TVLs is given by:

1

( 0.00611 )=log 164=¿ 2.21

( B1 )=¿ log ¿

x

n=log ¿

Barrier thickness (t) is given by:

t=34+ (2.21−1 ) × 29=69.09 cm

For 10MV:

2

P× d L 0.1× 10−3 × ( 7.62 ) 0.005776

B L ( 10 MV ) = −3 = = =0.00755

10 ×W × T 0.0 01× 765× 1 0.765

Then the number of TVLs is given by:

1

( 0.00755 )=log132.45=¿ 2.122

( B1 )=¿ log ¿

x

n=log ¿

Barrier thickness (t) is given by:

t=35+ ( 2.122−1 ) ×31=69.782≈ 70 cm

For 15MV:

P× d L2 0.1× 10−3 × ( 7.62 ) 0.005776

B L ( 15 MV ) = = = =0.0049

10−3 ×W × T 0.00 1× 1170×1 1.17

Then the number of TVLs is given by:

1 1

( ) Bx

=¿ log(0.0049 )

=log (204.08 )=2.31

n=log ¿

Barrier thickness (t) is given by:

t=36+ ( 2.31−1 ) × 33=79.23 cm

Since the leakage thicknesses required for 6MV, 10MV and 15MV are within one TVL of each other, one

HVL needs to be added according to the two source rule. Therefore, the total shielding to cover leakage

dose is:

'

t =t+ [ ( 0.301 ) ×TVL ] =79.23 cm+ [ ( 0.301 ) × 33 ]=89.2cm

Similar to point D, the instantaneous dose rate is below the limit.

Calculations done with P=20X10-6 Sv/week

20 ×10−6 ×7.6 2 0.001155

B L ( 06 MV )= = =0.0012

0.0 01× 945 ×1 0.945

Then the number of TVL is given by:

1

n=log ( 0.0012 )=log 833.3=2.92

Barrier thickness (t) is given by:

t=34+ (2.92−1 ) × 29=89.68 cm

For 10MV:

−6 2

20 × 10 × 7.6 0.001155

B L ( 10 MV ) = = =0.001509

0.001 ×765 ×1 0.765

**Then the number of TVL is given by:
**

1

n=log ( 0.001509 )=log 662.69=2.82

Barrier thickness (t) is given by:

t=35+ ( 2.82−1 ) ×31=91.42 cm

For 15MV:

−6 2

20 × 10 × 7.6 0.001155

B L ( 15 MV ) = = =0.00098

0.001 ×1170 × 1 1.17

Then the number of TVL is given by:

1

n=log ( 0.00098 )=log 1020.41=3.01

Barrier thickness (t) is given by:

t=36+ ( 3.01−1 ) ×33=102.33 cm

Since the leakage thickness required for 6MV, 10MV and 15MV are within one TVL of each othe, one HVL

needs to be added according to the two source rule. Therefore, the total shielding to cover leakage dose

is:

'

t =t+ [ ( 0.301 ) ×TVL ] =102.33 cm + [ ( 0.301 ) × 33 ] =112.3 cm

mSv

5

year mSv μSv

Controlled Area= =0.1 =100

weeks week week

50

year

mSv

1

year mSv μSv

Uncontrolled Area= =0.02 =20

weeks week week

50

year

Point ‘I’:

Occupancy Factor: 1/40=0.025

Distance from Iso to point dsec = 7.7m

Dose per week outside barrier (Uncontrolled) =20X10-6

Use factor (U) =0.25

α (15MV) scatter fraction for 60®=4.24x10-3

α (06MV) scatter fraction for 60®=8.24x10-4

α (10MV) scatter fraction for 60®=7.46x10-4

TVL (06MV, Scattered @30®=21cm

TVL (10MV, Scattered @30®=22cm

TVL (15MV, Scattered @30®=23cm

F=Field area at mid depth of patient @1m =40x40cm 2

IMRT workloads are used

**For 6MV the barrier thickness required is
**

2 2 2 2

P × d sec × d sca 400

−6

20 ×10 × 1 ×7.7 400 0.0011858

B ps ( 6 MV )=

α ×W × U × T

× ( = ) ×

40× 40 4.24 × 10 × 965 ×0.25 ×1 40 × 40

−3

= ( 1.0229 )

× 0.25=0.00028

Then the number of TVLs required is:

1

n=log ( 0.000289 )=log 3460.2=3.53

Barrier thickness (t) is given by:

t=n ×TVL=3.53 ×2 3=81.19 cm

**For 10MV, the barrier thickness required is
**

−6 2 2

20× 10 × 1 × 7.7 400 0.0011858

B ps ( 10 MV ) = −4

7.46 ×10 × 765 ×0.25 ×1

×

40 × (

40

= )

0.14626

× 0.25=0.00202

Then the number of TVLs required is:

1

n=log ( 0.00202 )=log 495.04=2.69

Barrier thickness (t) is given by:

t=n ×TVL=2.69 ×22=59.18 cm

**For 15MV, the barrier thickness required is
**

−6 2 2

20 × 10 × 1 ×7.7 400 0.0011858

B ps ( 15 MV ) = ×

4.24 ×10 ×1170 × 0.25× 1 40 × 40

−3

= ( 1.24 )×0.25=0.000239

Then the number of TVLs required is:

1

n=log ( 0.000239 )=log 4182.8=3.62

Barrier thickness (t) is given by:

t=n ×TVL=3.62 ×23=83.26 cm

Since scatter thicknesses required for 6,10 and 15MV are within 1TVL of each other, one HVL needs to be

added according to the two source rule. Therefore, the total shielding to cover patient scattered dose is:

**t ' =t+0.301 ( TVL )=83.26+0.301 ( 23 cm )=90.2 cm
**

Leakage calculation

P ×d L2 20 ×10−6 ×7.7 2 0.0011858

B L ( 06 MV )= = = =0.00123

10−3 × W ×T 0.001× 965 ×1 0.965

Then the number of TVLs is

1

n=log ( 0.00123 )=log 813.008=2.91

Barrier thickness (t) is given by:

t=34+ (2.91−1 ) × 29=89.39 cm

For 10MV,

P ×d L2 20 ×10−6 ×7.7 2 0.0011858

B L ( 06 MV )= = = =0.00155

10−3 × W ×T 0.001× 765 ×1 0.765

Then the number of TVLs is

1

n=log ( 0.00155 )=log 645.16=2.81

Barrier thickness (t) given by:

t=35+ ( 2.81−1 ) ×31=91.11 cm

For 15MV,

P× d L2 20 ×10−6 ×7.72 0.0011858

B L ( 15 MV ) = −3 = = =0.00101

10 ×W × T 0.001× 1170 ×1 1.17

Then the number of TVLs is

1

n=log ( 0.00101 )=log 990.1=2. 99

Barrier thickness (t) given by:

t=3 6+ ( 2. 99−1 ) ×3 3=101.67 cm

Since the leakage thicknesses required for 6, 10&15MV are within one TVL of each other, one HVL needs

to be added according to the two source rule. Therefore, the total shielding to cover leakage dose is:

t ' =t+0.301 ( TVL )=102 c m+0.301 ( 33 )=112 cm

- Lung Cancer (2)Uploaded byJae Kim
- Concurrent Radiotherapy and Weekly Paclitaxel for Locally Advanced Squmous Cell Carcinoma of Uterine Cervix–Treated Patients at Rural Centre in IndiaUploaded byIjsrnet Editorial
- south african radiographer journalUploaded byapi-274801053
- Radiation HazardUploaded byFaiq Syukri Bin Saparudin
- 10.1007@s00405-018-4985-5Uploaded byLuis Ignacio Baeza González
- Radiology Final Study GuideUploaded byEric Case
- wbi vs apbi ruthUploaded byapi-281676093
- Accurate Respiration Measurement Using DC-Coupled Continuous-Wave Radar Sensor for Motion-Adaptive Cancer RadiotherapyUploaded byh7q290587
- Radiotherapy for Your Lung at Velindre HospitalUploaded byObama
- radiationsafetyresearch-uwlaxUploaded byapi-337185638
- Oral CancerUploaded bykarmayagna
- Malignant Spinal Cord Compression-- Dealing the most common --MetsUploaded byDr Sasikumar Sambasivam
- Acute Effects of Radiation InjuryUploaded byVikas Vats
- para-aortic or nodal irradiation evaluationUploaded byapi-299189797
- fun with radiation-e2Uploaded byapi-292516931
- Colon CancerUploaded bySeli adalah Saya
- Impact of PET CT motion correction in minimizing the gross tumor volume in nonsmall cell lung cancerUploaded byLuid Beto
- case study finalUploaded byapi-265264098
- Breast Cancer ClinicalUploaded bybryantmaroney811
- Evaluacion Clinica e Histopatologica Del Sucralfate Para Tto de MucositisUploaded byMilton David Rios Serrato
- safety essayUploaded byapi-312374730
- terapi(bhs inggris)Uploaded byErwinSarwono
- Leukemia Treatment in India | Low Cost Leukemia Treatment in IndiaUploaded byindiacarez
- Introduction WasteUploaded bySafwan Shaikh
- 259_2013_Article_2510Uploaded byriezkytrinawati
- brain assignmentUploaded byapi-212894050
- Ppt for Lung CancerUploaded byMichael Jerome Parallag
- Nasopharyngeal Cancer CompleteUploaded byAmemonsajaah Amemon
- Oncology Nursing Handouts 1Uploaded bypauchanmnl
- Paediatric Soft Tissue TumoursUploaded byCoenraad van Schoor